MONTREAL, Oct. 1 /CNW/ - Manulife Financial strengthened its commitment
to Canadian healthcare today with a $1-million donation to the 'Thinking Ahead
Campaign' at the Montreal Neurological Institute and Hospital (MNI),
affiliated with McGill University and the McGill University Health Centre.
The donation by Manulife's Canadian Division was announced at an event in
Montreal by Manulife Financial President and Chief Executive Officer Dominic
D'Alessandro, who also personally donated $500,000 to the campaign.
Mr. D'Alessandro is co-chair of the MNI's fundraising campaign, which is a
five-year $40-million initiative to invest in people and expand facilities and
"Manulife is a global company and it is important for us to support
organizations like the Montreal Neurological Institute, whose influence
extends far beyond Canada's borders as a leading research facility,"
Mr. D'Alessandro said. "The MNI is embarking on brilliant and innovative
research programs to improve the quality of life of their patients and others
around the world."
David R. Colman, Director, MNI, added: "We are delighted that Manulife
and Dominic D'Alessandro have chosen to play such lead roles in our campaign.
Their support of the MNI will allow us to start up new research directions
that ultimately we hope will markedly improve the quality of life for those of
us who are debilitated by neurological disease."
Lead gifts from Brenda Milner, the Dorothy J. Killam Professor of
Neuropsychology at the MNI and the Cyril & Dorothy and Joel & Jill Reitman
Family Foundation were also announced today.
"Corporations and individuals have to step up to allow the kind of ground
breaking research that is necessary to lead the world," added Paul Rooney,
President and Chief Executive Officer, Manulife Canada. "I am pleased that
Manulife is in a position to help and believe that it is our responsibility to
do what we can to make a difference."
About the MNI
The Montreal Neurological Institute is a McGill University research and
teaching institute, dedicated to the study of the nervous system and
neurological diseases. Founded in 1934 by the renowned Dr. Wilder Penfield,
the MNI is one of the world's largest institutes of its kind. MNI researchers
are world leaders in cellular and molecular neuroscience, brain imaging,
cognitive neuroscience and the study and treatment of epilepsy, multiple
sclerosis and neuromuscular disorders. The MNI, with its clinical partner, the
Montreal Neurological Hospital (MNH), part of the McGill University Health
Centre, continues to integrate research, patient care and training, and is
recognized as one of the premier neuroscience centres in the world. At the
MNI, we believe in investing in the faculty, staff and students who conduct
outstanding research, provide advanced, compassionate care of patients and who
pave the way for the next generation of medical advances. Highly talented,
motivated people are the engine that drives research - the key to progress in
About Manulife Financial
Manulife Financial is a leading Canadian-based financial services group
serving millions of customers in 19 countries and territories worldwide.
Operating as Manulife Financial in Canada and Asia, and primarily through John
Hancock in the United States, the Company offers clients a diverse range of
financial protection products and wealth management services through its
extensive network of employees, agents and distribution partners. Funds under
management by Manulife Financial and its subsidiaries were Cdn$410 billion
(US$386 billion) as at June 30, 2007. Manulife Financial is one of only two
publicly traded life insurance companies with 'AAA'-rated insurance
subsidiaries, the highest rating for financial strength at Standard & Poor's
Rating Services. Manulife Financial Corporation trades as 'MFC' on the TSX,
NYSE and PSE, and under '0945' on the SEHK. Manulife Financial can be found on
the Internet at www.manulife.com.
For further information:
For further information: Media Contacts: Tom Nunn, Manulife Financial,
(519) 594-8578, firstname.lastname@example.org; Sandra McPherson, PhD, MNI, (514)